Edgewise Therapeutics
Price & Volume
Stats
See more52W Range | $12.30-$48.40 |
Market Cap | $5.2B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.74 |
News
See moreYahoo Finance • last month
Pre Market Movers: GNTA, HCWC, ZCMD Set The Path
Yahoo Finance • last month
Edgewise Therapeutics To Sell Muscular Dystrophy Business & Sevasemten For Up To $2.65 Bln
Yahoo Finance • 2 months ago
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally
Yahoo Finance • 2 months ago
Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More
About
CEO | Dr. Kevin Koch Ph.D. |
Address | 1715 38th Street, Boulder, CO, United States, 80301 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 154 |